Page last updated: 2024-10-21

xanthine and Bladder Cancer

xanthine has been researched along with Bladder Cancer in 1 studies

7H-xanthine : An oxopurine in which the purine ring is substituted by oxo groups at positions 2 and 6 and N-7 is protonated.
9H-xanthine : An oxopurine in which the purine ring is substituted by oxo groups at positions 2 and 6 and N-9 is protonated.

Research Excerpts

ExcerptRelevanceReference
"As for sex differences of urinary bladder tumors, the BrdU labeling index for epithelial cells of the urinary bladder by 5-week oral treatment with topiroxostat at 10 mg/kg to F344 rats was increased in males only, showing consistency with histopathological findings."1.40Xanthine crystals induced by topiroxostat, a xanthine oxidoreductase inhibitor, in rats, cause transitional cell tumors. ( Ashizawa, N; Iwanaga, T; Matsumoto, K; Moto, M; Saito, K; Shimo, T, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shimo, T1
Moto, M1
Ashizawa, N1
Matsumoto, K1
Iwanaga, T1
Saito, K1

Other Studies

1 other study available for xanthine and Bladder Cancer

ArticleYear
Xanthine crystals induced by topiroxostat, a xanthine oxidoreductase inhibitor, in rats, cause transitional cell tumors.
    Archives of toxicology, 2014, Volume: 88, Issue:4

    Topics: Administration, Oral; Animals; Calculi; Carcinoma, Transitional Cell; Cell Proliferation; Citric Aci

2014